We are live on
!
Find out more
DC
Defender Capital Portfolio holdings
AUM
$308M
1-Year Est. Return
4.52%
This Fund
S&P 500
This Quarter
Est. Return
+16.72%
1 Year Est. Return
+4.52%
3 Year Est. Return
+83.48%
5 Year Est. Return
+78.82%
10 Year Est. Return
–
AUM
$113M
AUM Growth
-$117K
(-0.1%)
Cap. Flow
+$3.38M
Cap. Flow
% of AUM
3%
Top 10 Holdings %
Top 10 Hldgs %
93.07%
Holding
19
New
1
Increased
9
Reduced
6
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AXON
Axon Enterprise
AXON
|
+$3.08M |
| 2 |
Monster Beverage
MNST
|
+$1.57M |
| 3 |
STAAR Surgical
STAA
|
+$601K |
| 4 |
Fortive
FTV
|
+$550K |
| 5 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$183K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$1.99M |
| 2 |
Enovis
ENOV
|
+$287K |
| 3 |
Danaher
DHR
|
+$156K |
| 4 |
Winmark
WINA
|
+$136K |
| 5 |
Inovio Pharmaceuticals
INO
|
+$129K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 32.82% |
| 2 | Financials | 22.78% |
| 3 | Consumer Staples | 17.27% |
| 4 | Technology | 15.3% |
| 5 | Consumer Discretionary | 3.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Berkshire Hathaway Class B
BRK.B
$1.06T
| $25.7M | 22.78% |
113,252
-9,165
| -7% | -$1.99M |
|
|
2
STAAR Surgical
STAA
$1.21B
| $21.2M | 18.81% |
602,453
+18,225
| +3% | +$601K |
|
|
3
Monster Beverage
MNST
$92.4B
| $19.4M | 17.27% |
612,020
+53,290
| +10% | +$1.57M |
|
|
4
Fortive
FTV
$18.5B
| $16.1M | 14.29% |
333,970
+12,179
| +4% | +$550K |
|
|
5
Enovis
ENOV
$1.56B
| $6.15M | 5.46% |
98,214
-5,084
| -5% | -$287K |
|
|
6
Winmark
WINA
$1.29B
| $3.7M | 3.28% |
18,636
-754
| -4% | -$136K |
|
|
AXON
7
Axon Enterprise
AXON
$41.2B
| $3.57M | 3.17% |
+48,695
| New | +$3.08M |
|
8
Lineage Cell Therapeutics
LCTX
$284M
| $3.54M | 3.14% |
3,977,045
+183,000
| +5% | +$152K |
|
|
9
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
| $2.98M | 2.65% |
49,000
+3,000
| +7% | +$183K |
|
10
Kinder Morgan
KMI
$72B
| $2.5M | 2.22% |
118,089
+211
| +0.2% | +$4.27K |
|
|
11
Danaher
DHR
$127B
| $2.13M | 1.89% |
156,535
-1,234
| -0.8% | -$156K |
|
|
12
Inovio Pharmaceuticals
INO
$90.5M
| $1.88M | 1.67% |
47,567
-4,291
| -8% | -$129K |
|
13
Compugen
CGEN
$236M
| $1.81M | 1.61% |
304,333
+7,000
| +2% | +$36K |
|
14
Apple
AAPL
$4.81T
| $696K | 0.62% |
9,484
+64
| +0.7% | +$4.12K |
|
15
Amazon
AMZN
$2.66T
| $453K | 0.4% |
4,900
+20
| +0.4% | +$1.77K |
|
16
Serina Therapeutics
SER
$31.3M
| $251K | 0.22% |
3,929
-1,903
| -33% | -$103K |
|
17
Microsoft
MSFT
$2.95T
| $240K | 0.21% |
1,520
| – | – |
|
18
Cisco
CSCO
$442B
| $208K | 0.18% |
4,349
| – | – |
|
|
FIT
19
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $131K | 0.12% |
20,000
| – | – |
|
Similar funds
PC
AWA
AC
EWM
ICP
ACM
GE
BBWA
Defender Capital's Q4 2019 Portfolio in Review
As of Q4 2019, Defender Capital held 19 positions worth $113M, down 0.1% from $113M the previous quarter. Its ten largest holdings account for 93% of the portfolio.
Defender Capital's Q4 2019 filing shows 1 new, 9 increased and 6 reduced positions. Its largest new stake was Axon Enterprise: 48,695 shares worth $3.57M. The largest sale was Berkshire Hathaway Class B, an estimated $1.99M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 42% a quarter earlier, followed by Financials and Consumer Staples.
- Defender Capital's largest Q4 2019 buy was Axon Enterprise: 48,695 shares worth $3.57M.
- Defender Capital added most to Monster Beverage in Q4 2019, an estimated $1.57M increase.
- Defender Capital's biggest Q4 2019 reduction was Berkshire Hathaway Class B, cutting an estimated $1.99M.
- Defender Capital's ten largest holdings make up 93% of its $113M portfolio in Q4 2019.
- Defender Capital opened 1 new position and closed 0 in Q4 2019.
- Defender Capital's portfolio value fell 0.1% quarter-over-quarter to $113M.
Based on Defender Capital's 13F filing for Q4 2019, filed 3 Feb 2020.